Your browser doesn't support javascript.
loading
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL).
Thiel, A; Schetelig, J; Pönisch, W; Schäfer-Eckart, K; Aulitzky, W; Peter, N; Schulze, A; Maschmeyer, G; Neugebauer, S; Herbst, R; Hänel, A; Morgner, A; Kroschinsky, F; Bornhäuser, M; Lange, T; Wilhelm, M; Niederwieser, D; Ehninger, G; Fiedler, F; Hänel, M.
Afiliação
  • Thiel A; Internal Medicine III, Department of Hematology, Oncology, Stem Cell Transplantation, Klinikum Chemnitz gGmbH, Chemnitz.
  • Schetelig J; Department of Internal Medicine I, University Hospital Carl Gustav Carus, University of Dresden, Dresden DKMS, German Bone Marrow Donor Center, Clinical Trials Unit, Dresden.
  • Pönisch W; Department of Hematology, Clinical Oncology and Hemostasiology, University of Leipzig, Leipzig.
  • Schäfer-Eckart K; Medical Clinic 5, Hematology and Oncology, Klinikum Nuernberg, Nuernberg.
  • Aulitzky W; Hematology and Oncology, Robert Bosch Krankenhaus, Stuttgart.
  • Peter N; Department of Oncology, Klinikum Carl Thiem, Cottbus.
  • Schulze A; Medical Clinic, Hematology/Oncology, Helios Clinic Erfurt GmbH, Erfurt.
  • Maschmeyer G; Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam.
  • Neugebauer S; WiSP Research, Langenfeld, Germany.
  • Herbst R; Internal Medicine III, Department of Hematology, Oncology, Stem Cell Transplantation, Klinikum Chemnitz gGmbH, Chemnitz.
  • Hänel A; Internal Medicine III, Department of Hematology, Oncology, Stem Cell Transplantation, Klinikum Chemnitz gGmbH, Chemnitz.
  • Morgner A; Internal Medicine III, Department of Hematology, Oncology, Stem Cell Transplantation, Klinikum Chemnitz gGmbH, Chemnitz.
  • Kroschinsky F; Department of Internal Medicine I, University Hospital Carl Gustav Carus, University of Dresden, Dresden.
  • Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, University of Dresden, Dresden.
  • Lange T; Department of Hematology, Clinical Oncology and Hemostasiology, University of Leipzig, Leipzig.
  • Wilhelm M; Medical Clinic 5, Hematology and Oncology, Klinikum Nuernberg, Nuernberg.
  • Niederwieser D; Department of Hematology, Clinical Oncology and Hemostasiology, University of Leipzig, Leipzig.
  • Ehninger G; Department of Internal Medicine I, University Hospital Carl Gustav Carus, University of Dresden, Dresden.
  • Fiedler F; Internal Medicine III, Department of Hematology, Oncology, Stem Cell Transplantation, Klinikum Chemnitz gGmbH, Chemnitz.
  • Hänel M; Internal Medicine III, Department of Hematology, Oncology, Stem Cell Transplantation, Klinikum Chemnitz gGmbH, Chemnitz m.haenel@skc.de.
Ann Oncol ; 26(7): 1434-40, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25922062

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article